These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 15572192)

  • 1. Antimicrobial activity of Bac7 fragments against drug-resistant clinical isolates.
    Benincasa M; Scocchi M; Podda E; Skerlavaj B; Dolzani L; Gennaro R
    Peptides; 2004 Dec; 25(12):2055-61. PubMed ID: 15572192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial activity of bovine bactericidal permeability-increasing protein-derived peptides against gram-negative bacteria isolated from the milk of cows with clinical mastitis.
    Chockalingam A; Zarlenga DS; Bannerman DD
    Am J Vet Res; 2007 Nov; 68(11):1151-9. PubMed ID: 17975968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A peptide derived from human bactericidal/permeability-increasing protein (BPI) exerts bactericidal activity against Gram-negative bacterial isolates obtained from clinical cases of bovine mastitis.
    Chockalingam A; McKinney CE; Rinaldi M; Zarlenga DS; Bannerman DD
    Vet Microbiol; 2007 Nov; 125(1-2):80-90. PubMed ID: 17560054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High potency and broad-spectrum antimicrobial peptides synthesized via ring-opening polymerization of alpha-aminoacid-N-carboxyanhydrides.
    Zhou C; Qi X; Li P; Chen WN; Mouad L; Chang MW; Leong SS; Chan-Park MB
    Biomacromolecules; 2010 Jan; 11(1):60-7. PubMed ID: 19957992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial activity of a novel peptide deformylase inhibitor, LBM415, tested against respiratory tract and cutaneous infection pathogens: a global surveillance report (2003-2004).
    Watters AA; Jones RN; Leeds JA; Denys G; Sader HS; Fritsche TR
    J Antimicrob Chemother; 2006 May; 57(5):914-23. PubMed ID: 16549511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit.
    Sader HS; Jones RN; Dowzicky MJ; Fritsche TR
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):203-8. PubMed ID: 16105565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The activity of antimicrobial peptide S-thanatin is independent on multidrug-resistant spectrum of bacteria.
    Wu G; Li X; Fan X; Wu H; Wang S; Shen Z; Xi T
    Peptides; 2011 Jun; 32(6):1139-45. PubMed ID: 21453736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia.
    Fritsche TR; Sader HS; Stilwell MG; Dowzicky MJ; Jones RN
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):187-93. PubMed ID: 16105563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A family of brevinin-2 peptides with potent activity against Pseudomonas aeruginosa from the skin of the Hokkaido frog, Rana pirica.
    Conlon JM; Sonnevend A; Patel M; Al-Dhaheri K; Nielsen PF; Kolodziejek J; Nowotny N; Iwamuro S; Pál T
    Regul Pept; 2004 May; 118(3):135-41. PubMed ID: 15003829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and antimicrobial evaluation of new phenoxyacetamide derivatives.
    Raffa D; Migliara O; Daidone G; Maggio B; Schillaci D
    Boll Chim Farm; 2002; 141(1):3-7. PubMed ID: 12064055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A synthetic form of tracheal antimicrobial peptide has both bactericidal and antifungal activities.
    Lawyer C; Watabe M; Pai S; Bakir H; Eagleton L; Mashimo T; Watabe K
    Drug Des Discov; 1996 Dec; 14(3):171-8. PubMed ID: 9017361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antimicrobial activity of dermaseptin S1 analogues.
    Savoia D; Guerrini R; Marzola E; Salvadori S
    Bioorg Med Chem; 2008 Sep; 16(17):8205-9. PubMed ID: 18676150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predominance of Gram-negative bacilli and increasing antimicrobial resistance in nosocomial bloodstream infections at a university hospital in southern Taiwan, 1996-2003.
    Wu CJ; Lee HC; Lee NY; Shih HI; Ko NY; Wang LR; Ko WC
    J Microbiol Immunol Infect; 2006 Apr; 39(2):135-43. PubMed ID: 16604246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modifications on amphiphilicity and cationicity of unnatural amino acid containing peptides for the improvement of antimicrobial activity against pathogenic bacteria.
    Taira J; Kida Y; Yamaguchi H; Kuwano K; Higashimoto Y; Kodama H
    J Pept Sci; 2010 Nov; 16(11):607-12. PubMed ID: 20648478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tigecycline activity tested against 26,474 bloodstream infection isolates: a collection from 6 continents.
    Sader HS; Jones RN; Stilwell MG; Dowzicky MJ; Fritsche TR
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):181-6. PubMed ID: 16105562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel polycationic analogue of gratisin with antibiotic activity against both Gram-positive and Gram-negative bacteria.
    Tamaki M; Kokuno M; Suzuki Y; Iwama M; Shindo M; Uchida Y
    J Antibiot (Tokyo); 2008 Jan; 61(1):33-5. PubMed ID: 18305357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of tigecycline against 6792 Gram-negative and Gram-positive clinical isolates from the global Tigecycline Evaluation and Surveillance Trial (TEST Program, 2004).
    Hoban DJ; Bouchillon SK; Johnson BM; Johnson JL; Dowzicky MJ;
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):215-27. PubMed ID: 16105567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potency and spectrum trends for cefepime tested against 65746 clinical bacterial isolates collected in North American medical centers: results from the SENTRY Antimicrobial Surveillance Program (1998-2003).
    Sader HS; Fritsche TR; Jones RN
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):265-73. PubMed ID: 16105569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro antibacterial activity of aminosterols against multidrug-resistant bacteria from patients with cystic fibrosis.
    Alhanout K; Brunel JM; Raoult D; Rolain JM
    J Antimicrob Chemother; 2009 Oct; 64(4):810-4. PubMed ID: 19666647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial susceptibility of tigecycline and comparators against bacterial isolates collected as part of the TEST study in Europe (2004-2007).
    Nørskov-Lauritsen N; Marchandin H; Dowzicky MJ
    Int J Antimicrob Agents; 2009 Aug; 34(2):121-30. PubMed ID: 19342205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.